JP2017526744A5 - - Google Patents

Download PDF

Info

Publication number
JP2017526744A5
JP2017526744A5 JP2017528765A JP2017528765A JP2017526744A5 JP 2017526744 A5 JP2017526744 A5 JP 2017526744A5 JP 2017528765 A JP2017528765 A JP 2017528765A JP 2017528765 A JP2017528765 A JP 2017528765A JP 2017526744 A5 JP2017526744 A5 JP 2017526744A5
Authority
JP
Japan
Prior art keywords
liposome
peg
antifolate
poly
dspe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017528765A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017526744A (ja
JP6825764B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/045353 external-priority patent/WO2016025882A2/en
Publication of JP2017526744A publication Critical patent/JP2017526744A/ja
Publication of JP2017526744A5 publication Critical patent/JP2017526744A5/ja
Application granted granted Critical
Publication of JP6825764B2 publication Critical patent/JP6825764B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017528765A 2014-08-14 2015-08-14 リポソームカプセル化親和性薬物 Active JP6825764B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462037597P 2014-08-14 2014-08-14
US62/037,597 2014-08-14
US201562130493P 2015-03-09 2015-03-09
US62/130,493 2015-03-09
US201562133265P 2015-03-13 2015-03-13
US62/133,265 2015-03-13
PCT/US2015/045353 WO2016025882A2 (en) 2014-08-14 2015-08-14 Liposome encapsulated affinity drug

Publications (3)

Publication Number Publication Date
JP2017526744A JP2017526744A (ja) 2017-09-14
JP2017526744A5 true JP2017526744A5 (cg-RX-API-DMAC10.html) 2018-09-20
JP6825764B2 JP6825764B2 (ja) 2021-02-03

Family

ID=55304769

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017528765A Active JP6825764B2 (ja) 2014-08-14 2015-08-14 リポソームカプセル化親和性薬物

Country Status (15)

Country Link
US (2) US20160228573A1 (cg-RX-API-DMAC10.html)
EP (1) EP3188724B1 (cg-RX-API-DMAC10.html)
JP (1) JP6825764B2 (cg-RX-API-DMAC10.html)
KR (1) KR102505508B1 (cg-RX-API-DMAC10.html)
CN (2) CN117159470A (cg-RX-API-DMAC10.html)
AP (1) AP2017009766A0 (cg-RX-API-DMAC10.html)
AU (4) AU2015301462B2 (cg-RX-API-DMAC10.html)
BR (1) BR112017002767B1 (cg-RX-API-DMAC10.html)
CA (1) CA2957775C (cg-RX-API-DMAC10.html)
DK (1) DK3188724T3 (cg-RX-API-DMAC10.html)
EA (1) EA201790378A1 (cg-RX-API-DMAC10.html)
ES (1) ES2905498T3 (cg-RX-API-DMAC10.html)
MA (1) MA40428A (cg-RX-API-DMAC10.html)
MX (1) MX386433B (cg-RX-API-DMAC10.html)
WO (1) WO2016025882A2 (cg-RX-API-DMAC10.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6375289B2 (ja) 2012-04-05 2018-08-15 マサチューセッツ インスティテュート オブ テクノロジー 免疫刺激組成物およびその使用方法
CN108289845A (zh) 2015-09-14 2018-07-17 维吉思康科技公司 皮下、舌下和口服治疗用空间稳定载体、用于治疗哺乳动物的组合物和方法
US10940112B2 (en) 2016-05-04 2021-03-09 L.E.A.F. Holdings Group Llc Targeted liposomal gemcitabine compositions and methods thereof
US20180236098A1 (en) 2016-08-12 2018-08-23 L.E.A.F. Holdings Group Llc Alpha and gamma-d polyglutamated antifolates and uses thereof
WO2018031979A1 (en) 2016-08-12 2018-02-15 L.E.A.F. Holdings Group Llc Alpha and gamma-d polyglutamated antifolates and uses thereof
KR102584446B1 (ko) 2016-08-12 2023-10-04 엘.이.에이.에프. 홀딩스 그룹 엘엘씨. 알파 및 감마-d 폴리글루타메이트화 항엽산 및 이의 용도
CN106750252B (zh) * 2016-12-05 2018-11-30 山东大学齐鲁医院 二硬脂酰基磷脂酰乙醇胺-聚乙二醇2000-双叶酸及其制备方法和应用
CA3061267A1 (en) * 2017-04-07 2018-10-11 Maa Laboratories, Inc. Methods of improving the solubility and bioavailability of therapeutic agents
PL3615005T3 (pl) 2017-04-28 2025-10-06 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Kompozycje i sposoby dostarczania szczepionki
WO2019157148A1 (en) * 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Gamma polyglutamated antifolates and uses thereof
WO2019157146A1 (en) * 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Alpha polyglutamated antifolates and uses thereof
JP7514533B2 (ja) * 2018-02-07 2024-07-11 エル.イー.エー.エフ. ホールディングス グループ エルエルシー アルファポリグルタミン酸化テトラヒドロ葉酸およびその使用
JP7491573B2 (ja) * 2018-02-07 2024-05-28 エル.イー.エー.エフ. ホールディングス グループ エルエルシー アルファポリグルタミン酸化メトトレキセートおよびその使用
WO2019157133A1 (en) 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Alpha polyglutamated raltitrexed and uses thereof
CA3090391A1 (en) 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Gamma polyglutamated raltitrexed and uses thereof
US12246018B2 (en) * 2018-02-07 2025-03-11 L.E.A.F. Holdings Group Llc Gamma polyglutamated pemetrexed and uses thereof
US12246019B2 (en) * 2018-02-07 2025-03-11 L.E.A.F. Holdings Group Llc Alpha polyglutamated lometrexol and uses thereof
US12220431B2 (en) 2018-02-07 2025-02-11 L.E.A.F. Holdings Group Llc Gamma polyglutamated antifolates and uses thereof
WO2019157129A1 (en) 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Alpha polyglutamated pralatrexate and uses thereof
EP3749317A4 (en) 2018-02-07 2022-06-22 L.E.A.F Holdings Group LLC PEMETREXED ALPHA-POLYGLUTAMATE AND ASSOCIATED USES
CA3090384A1 (en) * 2018-02-07 2019-08-15 L.E.A.F. Holdings Group Llc Alpha polyglutamated aminopterin and uses thereof
CA3090875A1 (en) 2018-02-14 2019-08-22 L.E.A.F. Holdings Group Llc Gamma polyglutamated lometrexol and uses thereof
US12048767B2 (en) * 2018-02-14 2024-07-30 L.E.A.F. Holdings Group Llc Gamma polyglutamated pralatrexate and uses thereof
JP7442822B2 (ja) * 2018-02-14 2024-03-05 エル.イー.エー.エフ. ホールディングス グループ エルエルシー γポリグルタミン酸化テトラヒドロ葉酸およびその使用
CA3090943A1 (en) * 2018-02-14 2019-08-22 L.E.A.F. Holdings Group Llc Gamma polyglutamated aminopterin and uses thereof
US12290518B2 (en) 2018-02-14 2025-05-06 L.E.A.F. Holdings Group Llc Gamma polyglutamated methotrexate and uses thereof
GB201814959D0 (en) * 2018-09-14 2018-10-31 Secr Defence Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses
JP2022525781A (ja) 2019-03-20 2022-05-19 マサチューセッツ インスティテュート オブ テクノロジー 免疫細胞療法における両親媒性物質の使用およびそのための組成物
AU2020269626B2 (en) * 2019-05-07 2026-01-22 Universidade Do Minho Method for production of liposomes
WO2020257260A1 (en) 2019-06-17 2020-12-24 Massachusetts Institute Of Technology Formulation of peptide loaded liposomes and related applications
WO2021150770A1 (en) * 2020-01-21 2021-07-29 University Of Virginia Patent Foundation Oncogenic trim37 is a targetable epigenetic driver of metastasis and links chemoresistance and metastatic fate in triple-negative breast cancer
EP4228660A4 (en) * 2020-10-14 2025-02-26 Georgia Tech Research Corporation Synthetic antigens as chimeric antigen receptor (car) ligands and uses thereof
AU2022270670A1 (en) 2021-05-05 2023-11-30 Nejat Duzgunes Liposome-encapsulated corticosteriods inhibit sars-cov-2 replication and reduces lung inflammation
WO2025005632A1 (ko) * 2023-06-26 2025-01-02 주식회사 무진메디 이온화 가능한 펩타이드를 이용한 지질 나노입자 기반 약물 전달체 및 이의 제조방법
KR102898792B1 (ko) * 2023-06-26 2025-12-19 주식회사 무진메디 이온화 가능한 펩타이드를 이용한 지질 나노입자 기반 약물 전달체 및 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646253A (en) 1994-03-08 1997-07-08 Memorial Sloan-Kettering Cancer Center Recombinant human anti-LK26 antibodies
CN100346784C (zh) * 2002-02-22 2007-11-07 先灵公司 抗肿瘤剂,特别是替莫唑胺的药物制剂,其制备方法和用途
US20100210745A1 (en) * 2002-09-09 2010-08-19 Reactive Surfaces, Ltd. Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
WO2005092388A1 (ja) * 2004-03-26 2005-10-06 Terumo Kabushiki Kaisha リポソーム製剤
US20110022529A1 (en) 2009-07-22 2011-01-27 Fernando Barsoba Social network creation using image recognition
SG184127A1 (en) * 2010-03-19 2012-10-30 Massachusetts Inst Technology Lipid vesicle compositions and methods of use
WO2011150392A1 (en) * 2010-05-28 2011-12-01 Purdue Research Foundation Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
WO2012031205A2 (en) * 2010-09-03 2012-03-08 The Brigham And Women's Hospital, Inc. Lipid-polymer hybrid particles
EP2614084A4 (en) * 2010-09-09 2014-02-19 Purdue Research Foundation HUMANE FOLAT RECEPTOR BETA ANTIBODIES AND METHOD FOR THEIR USE
EP3494974B1 (en) * 2011-07-08 2023-10-18 The University of North Carolina at Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
LT2731591T (lt) * 2011-07-13 2020-12-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Liposomos, kuriose kartu inkapsuliuotas bisfosfonatas ir amfipatinis agentas
US20130122096A1 (en) * 2011-11-14 2013-05-16 Silenseed Ltd. Compositions for drug delivery and methods of manufacturing and using same
EP2789348B1 (en) * 2011-12-07 2021-08-04 Universidade do Minho Liposomes and corresponding production method
US20140120157A1 (en) * 2012-09-19 2014-05-01 Georgetown University Targeted liposomes

Similar Documents

Publication Publication Date Title
JP2019524885A5 (cg-RX-API-DMAC10.html)
JP2019524802A5 (cg-RX-API-DMAC10.html)
JP2021513550A5 (cg-RX-API-DMAC10.html)
JP2021513529A5 (cg-RX-API-DMAC10.html)
KR102584446B1 (ko) 알파 및 감마-d 폴리글루타메이트화 항엽산 및 이의 용도
JP2021513525A5 (cg-RX-API-DMAC10.html)
JP2021513533A5 (cg-RX-API-DMAC10.html)
JP2025072362A5 (cg-RX-API-DMAC10.html)
JP2021512895A5 (cg-RX-API-DMAC10.html)
JP2021513528A5 (cg-RX-API-DMAC10.html)
JP2021513531A5 (cg-RX-API-DMAC10.html)
O Elzoghby et al. Natural polymeric nanoparticles for brain-targeting: implications on drug and gene delivery
Urban et al. Nanotools for the delivery of antimicrobial peptides
Zhao et al. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents
US20170232115A1 (en) Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
JP2021514357A5 (cg-RX-API-DMAC10.html)
KR20160110410A (ko) 하이브리도좀, 이를 포함하는 조성물, 이의 제조 방법 및 이의 용도
JP2016513090A5 (cg-RX-API-DMAC10.html)
BR112017002767B1 (pt) Composição de antifolato lipossomal, seu uso, método de preparação da mesma e kit
JP7803714B2 (ja) 複数のリガンドで機能化されたポリマーソーム
US20210393799A1 (en) Dendritic polymers complexed with immune checkpoint inhibitors for enhanced cancer immunotherapy
Shi et al. Advances in nanotherapy for targeting senescent cells
Zhang et al. Advances in long-circulating drug delivery strategy
Talevi et al. Applications of nanosystems to anticancer drug therapy (Part I. Nanogels, nanospheres, nanocapsules)
Zhang et al. Distinctive polymer micelle designed for siRNA delivery and reversal of MDR1 gene‐dependent multidrug resistance